Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

China Pharma Holdings (CPHI) Accumulated Depreciation & Amortization (2016 - 2025)

China Pharma Holdings filings provide 16 years of Accumulated Depreciation & Amortization readings, the most recent being $33.5 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 4.33% to $33.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.5 million, a 4.33% increase, with the full-year FY2025 number at $33.5 million, up 4.33% from a year prior.
  • Accumulated Depreciation & Amortization hit $33.5 million in Q4 2025 for China Pharma Holdings, up from $33.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $33.5 million in Q4 2025 to a low of $26.1 million in Q2 2021.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $29.4 million (2023), compared with a mean of $30.0 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: increased 22.77% in 2021 and later increased 0.68% in 2022.
  • China Pharma Holdings' Accumulated Depreciation & Amortization stood at $28.2 million in 2021, then increased by 0.68% to $28.4 million in 2022, then grew by 7.21% to $30.4 million in 2023, then grew by 5.61% to $32.1 million in 2024, then increased by 4.33% to $33.5 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $33.5 million (Q4 2025), $33.0 million (Q3 2025), and $32.6 million (Q2 2025) per Business Quant data.